Pharmaceutical companies in the United States by operating margin
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Royalty Pharma leads the 27 pharmaceutical companies in the United States ranked by operating margin, at 65.6%, ahead of PTC Therapeutics (50.1%) and United Therapeutics (46.9%). Figures as of 20 Nov 2026, 00:52 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 27
- First
- Royalty Pharma65.6%
- Median
- 5.88%
- Combined market value
- SAR 14.01T
- Countries
- 1
- Not ranked
- 17no operating margin on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Operating margin ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Royalty PharmaRPRX · Health Care | 65.6% | SAR 146.1B | SAR 254.02 | 1.38% down | 79% up | ||
| 2 | PTC TherapeuticsPTCT · Health Care | 50.1% | SAR 18.3B | SAR 218.78 | 3.16% down | 21% down | ||
| 3 | United TherapeuticsUTHR · Health Care | 46.9% | SAR 89.3B | SAR 2,097.18 | 3.16% down | 22% up | ||
| 4 | Vertex PharmaceuticalsVRTX · Health Care | 34.8% | SAR 495.2B | SAR 1,953.00 | 2.94% down | 27% up | ||
| 5 | Regeneron PharmaceuticalsREGN · Health Care | 24.9% | SAR 358.3B | SAR 3,463.45 | 2.35% down | 28% up | ||
| 6 | AbbVieABBV · Health Care | 24.6% | SAR 1.88T | SAR 1,063.56 | 0.86% down | 25% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | 20.0% | SAR 36.8B | SAR 243.36 | 1.88% down | 117% up | ||
| 8 | Abbott LaboratoriesABT · Health Care | 18.2% | SAR 674.8B | SAR 389.62 | 0.58% down | 16% down | ||
| 9 | Ligand PharmaceuticalsLGND · Health Care | 15.3% | SAR 21.5B | SAR 1,076.31 | 3.94% down | 50% up | ||
| 10 | Alnylam PharmaceuticalsALNY · Health Care | 13.5% | SAR 74.3B | SAR 554.47 | 1.06% down | 66% down | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | 13.1% | SAR 28B | SAR 80.23 | 2.24% down | 90% up | ||
| 12 | BioMarin PharmaceuticalBMRN · Health Care | 12.7% | SAR 44.6B | SAR 230.39 | 0.02% down | 17% up | ||
| 13 | Arrowhead PharmaceuticalsARWR · Health Care | 11.9% | SAR 23.1B | SAR 163.73 | 1.25% up | 13% up | ||
| 14 | Corcept TherapeuticsCORT · Health Care | 5.88% | SAR 26.7B | SAR 243.74 | 4.15% down | 10% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | -4.25% | SAR 23.4B | SAR 358.26 | 3.27% up | 34% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | -12.8% | SAR 17.4B | SAR 181.17 | 3.86% down | 45% up | ||
| 17 | Legend BiotechLEGN · Health Care | -13.3% | SAR 11.7B | SAR 60.39 | 0.92% down | 41% down | ||
| 18 | ViatrisVTRS · Health Care | -18.6% | SAR 85.5B | SAR 74.57 | 1.97% down | 99% up | ||
| 19 | Axsome TherapeuticsAXSM · Health Care | -26.1% | SAR 26.8B | SAR 508.94 | 1.25% up | 6% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | -31.3% | SAR 34.6B | SAR 1,488.17 | 0.34% down | 27% down | ||
| 21 | Ionis PharmaceuticalsIONS · Health Care | -40.4% | SAR 17B | SAR 102.10 | 0.62% down | 63% down | ||
| 22 | Rhythm PharmaceuticalsRYTM · Health Care | -101% | SAR 30.4B | SAR 438.12 | 1.88% down | 18% up | ||
| 23 | BridgeBio PharmaBBIO · Health Care | -104% | SAR 57.1B | SAR 293.25 | 0.22% up | 21% up | ||
| 24 | InsmedINSM · Health Care | -206% | SAR 118.9B | SAR 541.87 | 20.58% up | 40% down | ||
| 25 | Protagonist TherapeuticsPTGX · Health Care | -344% | SAR 30.4B | SAR 465.20 | 2.47% down | 51% up | ||
| 26 | CytokineticsCYTK · Health Care | -695% | SAR 26.9B | SAR 193.03 | 0.27% up | 19% down | ||
| 27 | Dianthus TherapeuticsDNTH · Health Care | -8739% | SAR 17.9B | SAR 318.20 | 1.01% up | 108% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Operating margin is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Banks and insurers report no operating income and are not ranked on it. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR). 17 companies have no operating margin on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by operating margin?
Royalty Pharma (65.6%), PTC Therapeutics (50.1%) and United Therapeutics (46.9%) are the top three of the 27 pharmaceutical companies in the United States ranked by operating margin as of 20 Nov 2026, 00:52 UTC.
How many pharmaceutical companies in the United States are in this ranking?
27 are ranked by operating margin. 17 more have no operating margin on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 27 pharmaceutical companies in the United States ranked by operating margin have a combined market value of SAR 14.01T as of 20 Nov 2026, 00:52 UTC.
What does ranking by operating margin measure?
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by operating margin”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=operating-margin
Underlying data: Yahoo Finance; SEC EDGAR.